Thomas Sciascia, Chief Scientific Officer: Trevi Therapeutics TRVI Sell · Filed 25/03/26

Trade details

Type: Insider sale
Amount: $17,364.6
Shares · price: 2,631 sh · $6.60 a share
Held after: 221,373 sh
Stock: Trevi Therapeutics TRVI
Person: Thomas SciasciaChief Scientific Officer
Trade date: 25/03/25
Filed: 25/03/26
Days to filing: 1 days

Sold 1.2% of holdings

Share of holding sold: 1.2%

Trevi Therapeutics trades, last 26 weeks

What else happened in Trevi Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/23~25/04/24

Thomas Sciascia's recent trades

Thomas SciasciaChief Scientific Officer
SellTrevi Therapeutics
Sell
Trevi Therapeutics
TRVI
$48.8K
16,496 sh
$48.8K
Filed 24/08/21
Traded 24/08/19
Thomas SciasciaChief Scientific Officer
SellTrevi Therapeutics
Sell
Trevi Therapeutics
TRVI
$51.5K
18,660 sh
$51.5K
Filed 24/08/16
Traded 24/08/16
Thomas SciasciaChief Scientific Officer
SellTrevi Therapeutics
Sell
Trevi Therapeutics
TRVI
$35.6K
12,745 sh
$35.6K
Filed 24/08/16
Traded 24/08/15
Thomas SciasciaChief Scientific Officer
SellTrevi Therapeutics
Sell
Trevi Therapeutics
TRVI
$275
100 sh
$275
Filed 24/08/16
Traded 24/08/14
Thomas SciasciaChief Scientific Officer
SellTrevi Therapeutics
Sell
Trevi Therapeutics
TRVI
$136.1K
53,368 sh
$136.1K
Filed 24/05/31
Traded 24/05/29